Back to Agenda
Session 2a
Session Chair(s)
Fengyun (Vicky) Han
Senior Director, Head of Regulatory Policy for Asia Pacific, Johnson & Johnson Pte. Ltd., Singapore
Audrey Ooi, MSc
Head- Business Development, Clinical Research Malaysia, Malaysia
Speaker(s)
Innovations in the Conduct of Early Phase Clinical Trials
Aaron Tan
Medical Oncologist, National Cancer Centre Singapore, Singapore
Opportunities and Challenges in Radioligand Therapy Trials
HV Bimba, MD
Senior Clinical Research Medical Advisor, Global Drug Development, Novartis Singapore Pte. Ltd., Singapore
Revolutionizing Oncology Drug Development with Circulating Tumor Cells- Derived Organoids from Solid Tumors
Shian Jiun Shih
Director Assay Development, Cell Genesys, United States
The Use of RWE in Drug Development
Susan Song
Director, Real World Evidence Growth, Parexel International , Singapore
Have an account?